scispace - formally typeset
L

Lucrezia Colonna

Researcher at University of Washington

Publications -  31
Citations -  4271

Lucrezia Colonna is an academic researcher from University of Washington. The author has contributed to research in topics: CD8 & T cell. The author has an hindex of 16, co-authored 29 publications receiving 3448 citations. Previous affiliations of Lucrezia Colonna include The Catholic University of America & Fred Hutchinson Cancer Research Center.

Papers
More filters
Journal ArticleDOI

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.

Carly G. K. Ziegler, +135 more
- 28 May 2020 - 
TL;DR: The data suggest that SARS-CoV-2 could exploit species-specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection.
Journal ArticleDOI

A specialized vascular niche for adult neural stem cells.

TL;DR: The vasculature is a key component of the adult SVZ neural stem cell niche, with SVZ stem cells and transit-amplifying cells uniquely poised to receive spatial cues and regulatory signals from diverse elements of the vascular system.
Journal ArticleDOI

Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II

TL;DR: Data reveal a novel ITAM-mediated inhibitory signaling pathway in DCs triggered by MHC II engagement of LAG-3, providing a molecular mechanism in which regulatory T cells may suppress via modulating DC function.
Journal ArticleDOI

Fcγ Receptor IIB on Dendritic Cells Enforces Peripheral Tolerance by Inhibiting Effector T Cell Responses

TL;DR: FcγRIIB can contribute to peripheral tolerance maintenance by inhibiting DC activation alone or by also limiting processing of exogenously acquired Ag in the maintenance of peripheral CD8 T cell tolerance.
Journal ArticleDOI

Heart infarct in NOD-SCID mice: Therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells

TL;DR: Results indicate that, within the CD34+ cell population, theCD34+KDR+ fraction is responsible for the improvement in cardiac hemodynamics and hence represents the candidate active CD34-KDR– cell subset.